Baird raised the price target for the Agenus Inc (NASDAQ:AGEN) stock to “an Outperform”. The rating was released on June 06, 2023, according to finviz. We previously noted in another research note ...
Baird raised the price target for the Agenus Inc (NASDAQ:AGEN) stock to “an Outperform”. The rating was released on June 06, 2023, according to finviz. We previously noted in another research note ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Human life expectancy has doubled since the 1900s, mostly ...
Agenus is developing botensilimab and balstilimab for colorectal cancer, among other oncology indications. See why I continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback